Cambiotics

Cambiotics

Private
CopenhagenHealthcare & Life Scienceshttps://cambiotics.com/

Last Round

Seed

Feb 11, 2026

Total Funding Raised

$4.72M

Momentum Score

75 /100

Company Overview

Cambiotics is a biotechnology company developing a precision probiotic designed to help the body remove PFAS (per- and polyfluorinated alkyl substances), also known as 'forever chemicals'.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

precision probioticsPFAS removalforever chemicalsprobiotic supplementPFASPFAS detoxificationPFAS detoxdirect-to-consumerDTCbiohackingper- and polyfluorinated substancesmicrobiome healthproprietary probioticshealth optimizationgut healthdietary supplement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cambiotics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cambiotics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 11, 2026

Cambiotics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2026

    Partnered with EY consultants to refine go-to-market strategy.

  • Mar 24, 2026

    Partnered with LIFESCAN Wellness Centers for disease screenings.

Cambiotics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cambiotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cambiotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range10
Year Founded2024
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.